Suppr超能文献

在观察性数据中,低钠血症或其潜在机制与死亡风险相关吗?

Do Hyponatremia or Its Underlying Mechanisms Associate With Mortality Risk in Observational Data?

作者信息

Danziger John, Lee Joon, Mark Roger G, Celi Leo Anthony, Mukamal Kenneth J

机构信息

Beth Israel Deaconess Medical Center, Department of Medicine, Harvard Medical School, Boston, MA.

Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA.

出版信息

Crit Care Explor. 2020 Jan 29;2(1):e0074. doi: 10.1097/CCE.0000000000000074. eCollection 2020 Jan.

Abstract

OBJECTIVES

Whether unaccounted determinants of hyponatremia, rather than water excess per se, primarily associate with mortality in observational studies has not been explicitly examined.

DESIGN

Retrospective cohort study of the association between hyponatremia and mortality, stratified by outpatient diuretic use in three strata.

SETTING

An inception cohort of 13,661 critically ill patients from a tertiary medical center.

MEASUREMENTS AND MAIN RESULTS

Admission serum sodium concentrations, obtained within 12 hours of admission to the ICU, were the primary exposure. Hyponatremia was associated with 1.82 (95% CI, 1.56-2.11; < 0.001) higher odds of mortality, yet differed according to outpatient diuretic use (multiplicative interaction between thiazide and serum sodium < 133 mEq/L; = 0.002). Although hyponatremia was associated with a three-fold higher (odds ratio, 3.11; 95% CI, 2.32-4.17; < 0.001) odds of mortality among those prescribed loop diuretics, no increase of risk was observed among thiazide diuretic users (odds ratio, 0.87; 95% CI, 0.47-1.51; = 0.63). When examined as a continuous variable, each one mEq/L higher serum sodium was associated with 8% (odds ratio, 0.92; 95% CI, 0.90-0.94; < 0.001) lower odds of mortality in loop diuretic patients and 5% (odds ratio, 0.95; 95% CI, 0.93-0.96, < 0.001) lower in diuretic naïve patients, but was not associated with mortality risk among thiazide users (odds ratio, 0.99; 95% CI, 0.95-1.02; = 0.45).

CONCLUSIONS

Hyponatremia is not uniformly associated with increased mortality, but differs according to diuretic exposure. Our results suggest that the underlying pathophysiologic factors that lead to water excess, rather water excess itself, account in part for the association between hyponatremia and poor outcomes. More accurate estimations about the association between hyponatremia and outcomes might influence clinical decision-making.

摘要

目的

在观察性研究中,低钠血症未被解释的决定因素而非水过量本身是否主要与死亡率相关,尚未得到明确研究。

设计

对低钠血症与死亡率之间的关联进行回顾性队列研究,按门诊使用利尿剂情况分为三个层次。

地点

来自一家三级医疗中心的13661例危重症患者起始队列。

测量指标及主要结果

入住重症监护病房(ICU)12小时内测得的入院血清钠浓度为主要暴露因素。低钠血症与死亡率高1.82倍(95%置信区间[CI],1.56 - 2.11;P < 0.001)相关,但根据门诊利尿剂使用情况有所不同(噻嗪类利尿剂与血清钠<133 mEq/L之间存在相乘交互作用;P = 0.002)。尽管在使用袢利尿剂的患者中,低钠血症与死亡率高3倍(比值比[OR],3.11;95% CI,2.32 - 4.17;P < 0.001)相关,但在使用噻嗪类利尿剂的患者中未观察到风险增加(OR,0.87;95% CI,0.47 - 1.51;P = 0.63)。当将血清钠作为连续变量进行分析时,血清钠每升高1 mEq/L,使用袢利尿剂的患者死亡率低8%(OR,0.92;95% CI,0.90 - 0.94;P < 0.(此处原文可能有误,推测应为P < 0.001)),未使用利尿剂的患者死亡率低5%(OR,0.95;95% CI,0.93 - 0.96,P < 0.001),但与使用噻嗪类利尿剂患者的死亡风险无关(OR,0.99;95% CI,0.95 - 1.02;P = 0.45)。

结论

低钠血症并非均与死亡率增加相关,而是因利尿剂暴露情况而异。我们的结果表明,导致水过量的潜在病理生理因素而非水过量本身,在一定程度上解释了低钠血症与不良结局之间的关联。对低钠血症与结局之间关联的更准确估计可能会影响临床决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd8/7063901/6076ea0b0b8c/cc9-2-e0074-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验